MedPath

Comparison of intrathecal buprenorphine and morphine as adjuvant to hyperbaric Ropivacaine 0.75% in patients undergoing urological procedures.

Phase 4
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2023/08/056643
Lead Sponsor
SDM COLLEGE OF MEDICAL SCIENCE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients belonging to ASA I and ASA II

BMI <40

Exclusion Criteria

1.Patients allergic to drugs used in study

2.Duration of surgery more than 120 minutes 3.Having contraindications to spinal anesthesia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
We aim to find the better additive among intrathecal buprenorphine 60mcg & morphine 150mcg & as an adjuvant to Ropivacaine in terms of the mean duration of postoperative analgesia,hemodynamic variations & adverse effects.Timepoint: Baseline
Secondary Outcome Measures
NameTimeMethod
1)post operative pain score <br/ ><br>2)Total analgesic drug consumption in 24hrs. <br/ ><br>3)Adverse effectsTimepoint: 10min 30mins 1st hour 2nd h 4th hour 8th hour 16th hour & 24th hour.
© Copyright 2025. All Rights Reserved by MedPath